Back

Drug coated balloons-based approach versus conventional percutaneous coronary intervention with drug eluting stents for left anterior descending revascularization

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Revascularisation options in coronary artery disease Revascularisation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Mauro Gitto

Humanitas University, Milan (Italy)

7 More presentations in this session

Presentation thumbnail
Impact of revascularization on non-flow limiting lesions
Mr C. Boerhout (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Comparison among ultra-thin coronary stents: a network metanalysis
Doctor F. Bruno (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Ventricular arrhythmia without acute coronary syndrome as an indication for invasive coronary angiography
Doctor S. Kriechbaum (Bad Nauheim, DE)
Abstract Slides Video
Presentation thumbnail
Prevalence and outcomes of acute coronary syndrome patients with and without standard modifiable risk factors undergoing percutaneous coronary intervention
Doctor D. Dinh (Victoria, AU)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes of patients with late presentation STEMI undergoing percutaneous coronary revascularization.
Doctor P. Neef (Clydebank, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Revascularisation options in coronary artery disease

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Meta-analysis of randomized trials: DEB versus DES in patients with de novo coronary artery disease
thumbnail
Congress Presentation
Drug-coated balloon versus drug-eluting stent for de novo culprit lesion in acute coronary syndromes: a report from nationwide registry in japan
thumbnail
Congress Presentation
Drug-coated balloon versus drug-eluting stent revascularization in the treatment of de novo acute myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources